Return On Equity	(Mar 31 2023) 2023	(Mar 31 2022) 2022	(Mar 31 2021) 2021	(Mar 31 2020) 2020	(Mar 31 2019) 2019
Y / Y Equity Change	1.13 %	0.94 %	-19.64 %	10.39 %	-13.54 %
Y / Y Net Income Change	-56.33 %	-	-	-13.32 %	34.29 %
Return On Equity	1.47 %	3.4 %	-	11.59 %	14.76 %

TARO all Ratios >> Back to TARO Management Effectiveness >> See Quarterly TARO Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Mar 31 2023) ROE decreased compare to previous year to 1.47 %, due to detoriation of net income.

Financial Statements
Taro Pharmaceutical Industries Ltd's Equity	$ 1,731 Millions	Annual TARO's Balance sheet
Taro Pharmaceutical Industries Ltd's Annual Income	$ 25 Millions	Annual TARO's Income Statement
Where are TARO's Income coming from?		Visit TARO's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.